Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Sebastian, S, Lambe, T
Formaat:	Journal article
Gepubliceerd in:	MDPI 2018

Gelijkaardige items

Clinical Advances in Viral-Vectored Influenza Vaccines
door: Sarah Sebastian, et al.
Gepubliceerd in: (2018-05-01)

Viral vector vaccines
door: McCann, N, et al.
Gepubliceerd in: (2022)

Clinical development of viral vectored vaccines against MERS-COV
door: Ewer, K, et al.
Gepubliceerd in: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
door: D. A. Mezhenskaia, et al.
Gepubliceerd in: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
door: Bissett, C, et al.
Gepubliceerd in: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
door: Ewer (nee Russell), K, et al.
Gepubliceerd in: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
door: Cameron Bissett, et al.
Gepubliceerd in: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
door: Arunkumar, G, et al.
Gepubliceerd in: (2019)

Research advances in replication-deficient viral vector vaccines
door: Junna Wang, et al.
Gepubliceerd in: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
door: McMahon, M, et al.
Gepubliceerd in: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
door: Antrobus, R
Gepubliceerd in: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
door: Tully, C, et al.
Gepubliceerd in: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
door: Tully, C
Gepubliceerd in: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
door: Mullin, J, et al.
Gepubliceerd in: (2014)

Development of viral vectors for passive immunisation against influenza
door: Tan, TK
Gepubliceerd in: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
door: Marta Ulaszewska, et al.
Gepubliceerd in: (2023-01-01)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
door: Irina Isakova-Sivak, et al.
Gepubliceerd in: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
door: Antrobus, R, et al.
Gepubliceerd in: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
door: Antrobus, R, et al.
Gepubliceerd in: (2014)

Adenoviral vectors as novel vaccines for influenza.
door: Coughlan, L, et al.
Gepubliceerd in: (2015)

Virus-Vectored Influenza Virus Vaccines
door: Ralph A. Tripp, et al.
Gepubliceerd in: (2014-08-01)

Viral vectors for malaria vaccine development.
door: Li, S, et al.
Gepubliceerd in: (2007)

The use of viral vectors in vaccine development
door: Tatianna Travieso, et al.
Gepubliceerd in: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
door: Kenneth Lundstrom
Gepubliceerd in: (2016-11-01)

Developments in Viral Vector-Based Vaccines
door: Takehiro Ura, et al.
Gepubliceerd in: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
door: Ewer (nee Russell), K, et al.
Gepubliceerd in: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
door: Kapulu, MC
Gepubliceerd in: (2014)

Recombinant influenza A viruses as vaccine vectors
door: Thomas Gerlach, et al.
Gepubliceerd in: (2019-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
door: Katie Ewer, et al.
Gepubliceerd in: (2017-12-01)

Viral vectors as vaccine platforms: Deployment in sight
door: Rollier, C, et al.
Gepubliceerd in: (2011)

Novel viral vector vaccines for tropical infections
door: Rampling, T
Gepubliceerd in: (2017)

Viral vectors as vaccine platforms: deployment in sight.
door: Rollier, C, et al.
Gepubliceerd in: (2011)

Viral Vectors for COVID-19 Vaccine Development
door: Kenneth Lundstrom
Gepubliceerd in: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
door: Luis Jiménez-Cabello, et al.
Gepubliceerd in: (2020-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
door: Sushmita Kumari, et al.
Gepubliceerd in: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
door: Jianfeng Zhang
Gepubliceerd in: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
door: Shintaro Shichinohe, et al.
Gepubliceerd in: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
door: L. M. Khantimirova, et al.
Gepubliceerd in: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
door: McAuliffe, J
Gepubliceerd in: (2020)

Baculovirus expression vector system for production of viral vaccines /
door: 300419 Vlak, J. M., et al.